Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer

Abstract

Elevated expression of heme oxygenase-1 (HO-1), an intracellular enzyme that degrades heme into carbon monoxide (CO), biliverdine and free iron, has anti-inflammatory and antiapoptotic effects in diverse models. Here, we analyzed the effects of specific overexpression of HO-1 following adenovirus-mediated (AdHO-1) gene transfer in an acute cardiac allograft rejection model. The intragraft (i.g.) injection of AdHO-1 into cardiac allografts, as well as intramuscular (i.m.) or intravenous (i.v.) administration, prolonged allograft survival with, respectively, 13.3, 62.5 and 80% of the grafts surviving long term (>100 days), whereas control grafts were rejected with acute kinetics. HO-1 overexpression was associated with inhibited allogeneic responses in MLRs using graft-infiltrating leukocytes and splenocytes, but not with lymph node cells. The inhibition of splenocyte proliferation was mediated by soluble factors and was dependent on the presence of APCs, since purified T cells proliferated normally. i.v. but not i.g. AdHO-1 administration decreased the number of graft-infiltrating leukocytes, cytokine mRNA accumulation and apoptosis in transplanted hearts, whereas i.v. and i.g. AdHO-1 did not modify normal immune responses against cognate antigens, indicating that there was no general immunosuppression. These results indicate that HO-1 overexpression prolongs the survival of vascularized allografts by promoting tolerogenic mechanisms acting on allogeneic cellular immune responses.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Maines MD . The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37: 517–554.

    Article  CAS  Google Scholar 

  2. Otterbein LE, Choi AM . Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1029–L1037.

    Article  CAS  Google Scholar 

  3. Hancock WW, Buelow R, Sayegh MH, Turka LA . Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 1998; 4: 1392–1396.

    Article  CAS  Google Scholar 

  4. Woo J, Iyer S, Mori N, Buelow R . Alleviation of graft-versus-host disease after conditioning with cobalt-protoporphyrin, an inducer of heme oxygenase-1. Transplantation 2000; 69: 623–633.

    Article  CAS  Google Scholar 

  5. Woo J et al. Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32). Transplant Immunol 1998; 6: 84–93.

    Article  CAS  Google Scholar 

  6. Iyer S et al. Characterization and biological significance of immunosuppressive peptide D2702.75-84(E –>V) binding protein. Isolation of heme oxygenase-1. J Biol Chem 1998; 273: 2692–2697.

    Article  CAS  Google Scholar 

  7. Cuturi MC et al. RDP1258, a new rationally designed immunosuppressive peptide, prolongs allograft survival in rats: analysis of its mechanism of action. Mol Med 1999; 5: 820–832.

    Article  CAS  Google Scholar 

  8. Ignarro L, Barrot B, Wood K . Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. J Biol Chem 1984; 259: 6201–6207.

    CAS  PubMed  Google Scholar 

  9. Foresti R, Motterlini R . The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic Res 1999; 31: 459–475.

    Article  CAS  Google Scholar 

  10. Chauveau C et al. Gene transfer of heme-oxygenase 1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant 2002; 2: 581–592.

    Article  CAS  Google Scholar 

  11. Ke B et al. Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Hum Gene Ther 2002; 13: 1189–1199.

    Article  CAS  Google Scholar 

  12. Tsui TY et al. Prevention of chronic deterioration of heart allograft by recombinant adeno-associated virus-mediated heme oxygenase-1 gene transfer. Circulation 2003; 107: 2623–2629.

    Article  CAS  Google Scholar 

  13. Zhang Y et al. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol Ther 2001; 3: 697–707.

    Article  CAS  Google Scholar 

  14. Josien R et al. FAS-ligand, TNF-α expression and apoptosis during allograft rejection and tolerance. Transplantation 1998; 66: 887–893.

    Article  CAS  Google Scholar 

  15. Schnell MA et al. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther 2001; 3: 708–722.

    Article  CAS  Google Scholar 

  16. Labow D et al. Adenovirus vector-mediated gene transfer to regional lymph nodes. Hum Gene Ther 2000; 11: 759–769.

    Article  CAS  Google Scholar 

  17. Sarukhan A et al. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors. J Virol 2001; 75: 269–277.

    Article  CAS  Google Scholar 

  18. Larsen CP, Austyn JM, Morris PJ . The role of graft-derived dendritic leukocytes in the rejection of vascularized organ allografts. Recent findings on the migration and function of dendritic leukocytes after transplantation. Ann Surg 1990; 212: 308–315; (discussion 316–307).

    Article  CAS  Google Scholar 

  19. Saiki T, Ezaki T, Ogawa M, Matsuno K . Trafficking of host- and donor-derived dendritic cells in rat cardiac transplantation: allosensitization in the spleen and hepatic nodes. Transplantation 2001; 71: 1806–1815.

    Article  CAS  Google Scholar 

  20. Brouard S et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000; 192: 1015–1026.

    Article  CAS  Google Scholar 

  21. Araujo JA et al. Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse. J Immunol 2003; 171: 1572–1580.

    Article  CAS  Google Scholar 

  22. Butcher EC, Picker LJ . Lymphocyte homing and homeostasis. Science 1996; 272: 60–66.

    Article  CAS  Google Scholar 

  23. Maloy KJ, Powrie F . Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2: 816–822.

    Article  CAS  Google Scholar 

  24. Goerdt S, Orfanos C . Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999; 10: 137–142.

    Article  CAS  Google Scholar 

  25. Guillot C et al. Active suppression of allogeneic proliferative responses by dendritic cells after induction of long term allograft survival by CTLA4Ig. Blood 2003; 101: 3325–3333.

    Article  CAS  Google Scholar 

  26. Munn DH et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002; 297: 1867–1870.

    Article  CAS  Google Scholar 

  27. Harrison PM, Arosio P . Ferritins-molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta–Bioenergetics 1996; 1275: 161–203.

    Article  Google Scholar 

  28. Matzner Y et al. Suppressive effect of ferritin on in vitro lymphocyte function. Br J Haematol 1979; 42: 345–353.

    Article  CAS  Google Scholar 

  29. Gray CP, Arosio P, Hersey P . Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. Blood 2002; 99: 3326–3334.

    Article  CAS  Google Scholar 

  30. Nagakami T, Toyomura K, Kinoshita TSM . A beneficial role of bile pigments as an endogenous tissue protector: anticomplement effects of biliverdin and conjugated bilirubin. Biochem Biophys Acta 1993; 1158: 189–193.

    Article  Google Scholar 

  31. Stocker R et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043–1046.

    Article  CAS  Google Scholar 

  32. Haga Y, Tempero MA, Kay D, Zetterman RK . Intracellular accumulation of unconjugated bilirubin inhibits phytohemagglutin-induced proliferation and interleukin-2 production of human lymphocytes. Dig Dis Sci 1996; 41: 1468–1474.

    Article  CAS  Google Scholar 

  33. Haga Y, Tempero MA, Zetterman RK . Unconjugated bilirubin inhibits in vitro cytotoxic T lymphocyte activity of human lymphocytes. Biochim Biophys Acta 1996; 1317: 65–70.

    Article  Google Scholar 

  34. Soares MP et al. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 1998; 4: 1073–1077.

    Article  CAS  Google Scholar 

  35. Ono K, Lyndsey ES . Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1968; 57: 225–229.

    Google Scholar 

  36. He T et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci 1998; 95: 2509–2514.

    Article  CAS  Google Scholar 

  37. Guillot C et al. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. J Immunol 2000; 164: 5258–5268.

    Article  CAS  Google Scholar 

  38. ABI PRISM##ABI PRISM 7700 User Bulletin. PE Applied Biosystems: Foster City, CA, 1997, p. 14.

Download references

Acknowledgements

This work was financed in part by the Fondation Transvie, the Fondation Treille and EC Grant HO-1 QLK3-CT-2001-00422. We are grateful to all the researchers who kindly contributed reagents, to the Vector Core of the University Hospital of Nantes, supported by the Association Française contre les Myopathies (AFM), for producing the adenoviral vectors used in this study, to Dr B LeMauf for helpful discussions and to Claire Usal and Emmanuel Merieau for heart transplantation.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Braudeau, C., Bouchet, D., Tesson, L. et al. Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther 11, 701–710 (2004). https://doi.org/10.1038/sj.gt.3302208

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302208

Keywords

This article is cited by

Search

Quick links